共 9 条
[1]
Multidrug resistance in breastcancer:a meta-analysis of MDR1/gp170 expression and its pos-sible functional significance. Trock BJ,Leonessa F,Clarke R. Journal of the National Cancer Institute . 1997
[2]
COX-2 overexpression inpretreatment biopsies predicts response of rectal cancers to neoadju-vant radiochemotherapy. Smith FM,Reynolds JV,Kay EW,et al. International Journal of Radiation Oncology Biology Physics . 2006
[3]
Drug resistance in chemotherapyfor breast cancer. Saekit T,Tsuruo T,Sato W,et al. Cancer Chemother . 2005
[4]
P-glycoprotein expression in treated and untreated human breast cancer. Schneider J,Bak M,Efferth TH et al. British Journal of Cancer . 1989
[5]
Inhibition of cyclooxygenase(COX)-2 expression by Tet-inducible COX-2 antisense cDNAin hor-mone-refractory prostate cancer significantly slows tumor growthand improves efficacy of chemotherapeutic drugs. Dandekar DS,Lokeshwar BL. Clinical Cancer Research . 2004
[6]
Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. Patal VA,Dunn MJ,Sorokin A. Journal of Biological Chemistry . 2002
[7]
High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer. Xi H,Baldus SE,Warnecke-Eberz U, et al. Clinical Cancer Research . 2005
[9]
Drug resistance in chemotherapy for breast cancer[J] . Toshiaki Saeki,Takashi Tsuruo,Wakao Sato,Kiyoshiro Nishikawsa.  Cancer Chemotherapy and Pharmacology . 2005 (1)